Funding history
- $90M2026-08-11Source: news.google.com ↗
More Health companies
Recently funded startups in the same category.
Epicrispr is focused on developing epigenetic editing therapies for rare muscle diseases. The company aims to leverage its innovative technology to address unmet medical needs in this niche market. The recent funding will help advance their drug development efforts.
Recently funded startups in the same category.